Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...

They’re the seemingly miraculous solution to weight loss, helping people shed stubborn pounds that other diet and food ...

More than 1.6 million adults in ­England, Wales and Scotland used weight-loss drugs such as Wegovy and Mounjaro between early ...

As the pharma patent cliff approaches, delve into which important drugs are about to lose exclusivity and how the industry is reacting.

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

GLP-1 drugs like Ozempic and Wegovy are often portrayed as sudden breakthroughs, but their roots extend back more than a ...

Aly, a clinical epidemiologist and chief of research and development at VA St Louis Health Care System in the US, who led the ...

Ozempic may be more expensive and harder to find now that compounded semaglutide isn't available. Here are 9 reputable places ...

THE number of people taking “fat jabs” such as Mounjaro and Ozempic is on the rise. However, they present serious risks to ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...